Jeffrey L. Wade - 20 Jun 2023 Form 4 Insider Report for LEXICON PHARMACEUTICALS, INC. (LXRX)

Role
President and CFO
Signature
/s/ Jeffrey L. Wade
Issuer symbol
LXRX
Transactions as of
20 Jun 2023
Net transactions value
+$28,000
Form type
4
Filing time
20 Jun 2023, 16:10:33 UTC
Previous filing
01 Mar 2023
Next filing
14 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LXRX Common Stock Purchase $23,350 +10,000 +4.1% $2.34 252,341 20 Jun 2023 Direct
transaction LXRX Common Stock Purchase $4,650 +2,000 +0.79% $2.32 254,341 20 Jun 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.